JIA Consumer Care Guide
The Juvenile Idiopathic Arthritis (JIA) Consumer Care Guide has been funded by the Australian Government. Co-designed with parents of children
The Juvenile Idiopathic Arthritis (JIA) Consumer Care Guide has been funded by the Australian Government. Co-designed with parents of children
Arthritis Australia has launched a new Consumer Care Guide for Rheumatoid Arthritis (RA), funded by the Australian Government. Co-designed with
Kids from around the country have participated in recent JIA kids camps run in Northern NSW and the ACT, made
Despite arthritis being one of our most prevalent and expensive diseases, impacting over 3.6 million Australians (or 1 in 7)
Information about the Tocilizumab (Actemra®) Shortage Update 1 November 2022: changes to temporary PBS listings mean you may need to
We spoke to people living with inflammatory arthritis. They told us they wanted to understand what living well with the
Even though axial spondyloarthritis is the fourth most common form of arthritis, impacting around 1-2% Australians (15-40 years old),1 and
During 2020 and 2021, some people on biologic and targeted synthetic disease modifying anti-rheumatic drugs (b/tsDMARDs) for arthritis and other
During the 2022 federal election, Arthritis Australia sent a copy of our election platform and campaign flag to every federal
It can be hard to keep up with the health advice on COVID-19 vaccines, boosters, fourth shots, and new treatments